Dow Down 0.18% Nasdaq Up 0.39%

AVEO Pharmaceuticals, Inc. (AVEO)

-NasdaqGS
1.28 Down 0.04(3.03%) Sep 2, 4:15PM EDT
Prev Close:1.32
Open:1.32
Bid:1.05 x 200
Ask:2.30 x 200
1y Target Est:1.67
Beta:0.71
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:1.26 - 1.35
52wk Range:1.00 - 2.36
Volume:367,446
Avg Vol (3m):1,061,950
Market Cap:66.26M
P/E (ttm):N/A
EPS (ttm):-1.54
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
AVEODown 3.03%66.26M
AMGNDown 1.02%104.80B
PFEDown 0.44%185.53B
RHHBYUp 0.14%248.42B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.84
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.92
Quarterly EPS Est (Sep-14) :-0.23
Mean Recommendation*:3.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AVEO Pharmaceuticals, Inc., doing business as AVEO Oncology, a biopharmaceutical company, is engaged in discovering, developing, and commercializing targeted cancer therapies using its Human Response Platform. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback